These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 15040160)
1. [Dyslipidemia and the metabolic syndrome]. Soska V Vnitr Lek; 2003 Dec; 49(12):943-7. PubMed ID: 15040160 [TBL] [Abstract][Full Text] [Related]
2. [Diabetic dyslipidaemia and the atherosclerosis]. Márk L; Dani G Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274 [TBL] [Abstract][Full Text] [Related]
3. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Brunzell JD; Ayyobi AF Am J Med; 2003 Dec; 115 Suppl 8A():24S-28S. PubMed ID: 14678862 [TBL] [Abstract][Full Text] [Related]
4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of the dyslipidemia of the metabolic syndrome. Raal FJ Metab Syndr Relat Disord; 2009 Apr; 7(2):83-8. PubMed ID: 19400742 [TBL] [Abstract][Full Text] [Related]
6. Hypolipidemic therapy for the metabolic syndrome. Cignarella A; Bellosta S; Corsini A; Bolego C Pharmacol Res; 2006 Jun; 53(6):492-500. PubMed ID: 16621589 [TBL] [Abstract][Full Text] [Related]
7. Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins. Devroey D; Velkeniers B; Duquet W; Betz W Acta Cardiol; 2003 Jun; 58(3):179-84. PubMed ID: 12846506 [TBL] [Abstract][Full Text] [Related]
8. [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?]. Broedl UC; Lehrke M; Parhofer KG MMW Fortschr Med; 2008 Jun; 150(25):41-3. PubMed ID: 18705054 [No Abstract] [Full Text] [Related]
12. The metabolic syndrome: pathophysiology, clinical relevance, and use of niacin. Ito MK Ann Pharmacother; 2004 Feb; 38(2):277-85. PubMed ID: 14742767 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatment of type 2 diabetic dyslipidemia. Moon YS; Kashyap ML Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439 [TBL] [Abstract][Full Text] [Related]
15. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166 [TBL] [Abstract][Full Text] [Related]
16. Evaluation and treatment of lipid disorders in women. Zelis R Curr Womens Health Rep; 2003 Apr; 3(2):97-103. PubMed ID: 12628078 [TBL] [Abstract][Full Text] [Related]